未登录

F

Flora Au

university of calgary

H指数:19

被引数:1,284

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Women’s Health Workforce and Outpatient Care Delivery in Alberta: Evidence from 26 Years of Population-Based Data

阿尔伯塔省女性卫生人力资源与门诊医疗服务提供：基于26年基于人群数据的证据

IF3.4

2026-08-170

OAAI

Practice Variation in Prescribing SGLT2-Inhibitors: A Population-Based Analysis from Alberta, Canada

Kanji, R.; Chew, D.S.; Au, F.; Campbell, D.J.T.; Lau, D.; Beall, R.F.; Ronksley, P.E.; Manns, B.; Quinn, A.E. 药物处方中SGLT2抑制剂的应用差异：来自加拿大阿尔伯塔省的基于人群的分析。CJC Open 2025, 8, 283–291. [Google Scholar] [CrossRef]

IF1.9

2026-03-011

PRE

Starting Dialysis on Time, At Home on the Right Therapy (START): Cost analysis of an initiative to increase the use of peritoneal dialysis

适时开始透析，居家接受正确治疗（START）：一项旨在增加腹膜透析使用率的举措的成本分析

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

IF0

2025-12-260

OA

Physician payment models and cardiac imaging in patients at low cardiovascular risk: A population-based cohort study in Alberta, Canada

医生支付模式与低心血管风险患者的心脏影像学检查：加拿大阿尔伯塔省的一项基于人群的队列研究

IF2.6

2025-11-100

PRE

Taking the Pulse: A Retrospective, Population-Based Analysis of Alberta’s Privatization of Cardiac Testing

《测量脉搏：阿尔伯塔省心脏检测私有化的人口基回顾性分析》

Canadian Journal of Cardiology

IF5.3

2025-09-020

PREAI

Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation

IF7.4

2024-03-143

OAAI

Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada

加拿大艾伯塔省新诊断的2型糖尿病患者中二甲双胍的使用模式和糖化血红蛋白趋势

DIABETES OBESITY & METABOLISM

IF5.7

2024-01-021

OA

Physician Variation and the Impact of Payment Model in Cardiac Imaging

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2023-12-191

OAAI

Self-Management Support Using Advertising Principles for Older Adults With Low Income at High Cardiovascular Risk: A Randomized Controlled Trial

IF38.6

2023-05-164

OAAI

Eliminating Medication Copayments for Low-Income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial

IF38.6

2023-05-169

OAAI

Alert-driven vs scheduled remote monitoring of implantable cardiac defibrillators: A cost- consequence analysis from the TRUST trial

IF5.7

2023-03-017

PRE

Impact of payment model on the behaviour of specialist physicians: A systematic review

IF3.4

2020-04-0125

PREAI

A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH)

VALUE IN HEALTH

IF6

2019-10-019

OAAI

A cost-effectiveness analysis of mupirocin and chlorhexidine gluconate for Staphylococcus aureus decolonization prior to hip and knee arthroplasty in Alberta, Canada compared to standard of care

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL

IF4.4

2019-07-119

OAAI

Validity of administrative data in identifying complex surgical site infections from a population-based cohort after primary hip and knee arthroplasty in Alberta, Canada

AMERICAN JOURNAL OF INFECTION CONTROL

IF2.4

2018-10-0118

PREAI

The cost of managing complex surgical site infections following primary hip and knee arthroplasty: A population-based cohort study in Alberta, Canada

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2018-09-1021

PREAI

Health Care Costs in People With Diabetes and Their Association With Glycemic Control and Kidney Function

IF16.6

2013-04-1357

OAAI

Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2011-10-1125

OAAI

Nonmedical Costs of Colorectal Cancer Screening Using CT Colonography

JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY

IF5.1

2010-12-015

PREAI

Population based screening for chronic kidney disease: cost effectiveness study

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2010-11-0884

OAAI